Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program (Q40430211)

20 September 2017

Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program (English)

1 reference

20 September 2017

Al Baha Barqawi

1

1 reference

20 September 2017

Brian K Golden

2

1 reference

20 September 2017

Colin O'Donnell

3

1 reference

20 September 2017

Michael K Brawer

4

1 reference

20 September 2017

E David Crawford

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

65

1 reference

20 September 2017

4

1 reference

20 September 2017

708-712

1 reference

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Survival prospects after screen-detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Prostate cancer screening: what we know and what we need to know.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Measurement of complexed PSA improves specificity for early detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Complexed PSA performance for prostate cancer detection in an African-American population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Overweight and obesity in the United States: prevalence and trends, 1960-1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Obesity in relation to prostate cancer risk: comparison with a population having benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Relationship of body mass index and prostate specific antigen in a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

The stability of free and bound prostate-specific antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Lowering PSA cutoffs to enhance detection of curable prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

The disease burden associated with overweight and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Reduced testosterone and adrenal C19 steroid levels in obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Fat tissue: a steroid reservoir and site of steroid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.10.074

10.1016/J.UROLOGY.2004.10.074

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference